An archive of ADCC/CDC-enhanced antibodies developed by Creative Biolabs' state-of-the-art technology platform.
Fc silence antibody is a therapeutic antibody that achieves a reduction in Fc effector function, such as cytokine release, by mutating Fc regions. Creative Biolabs' best-in-class Fc Engineering technology platform enables you to produce Fc Silence therapeutic antibodies. Silencing Fc can attenuate or eliminate the interaction between Fc/FcγR and complement C1q, which is essential for therapeutic applications where activation of the host immune system has a negative impact. We use a variety of strategies to help you develop antibodies that truly silence the Fc domain.
Please search for the Fc Silent Antibody products you need. Or contact us directly to tailor a solution to your specific needs.
[Cat#: CB-LX001-A]
Anti-ADDL Fc Silent Antibody (4D5-8)
[Cat#: CB-LX002-A]
Anti-Amyloid-β Fc Silent Antibody (CB-LX002-A)
[Cat#: CB-LX003-A]
Anti-B7-H4 Fc Silent Antibody (7A1-6)
[Cat#: CB-LX004-A]
Anti-C5 Fc Silent Antibody (CB-LX004-A)
[Cat#: CB-LX005-A]
Anti-CD11a Fc Silent Antibody (CB-LX005-A)
[Cat#: CB-LX006-A]
Anti-CD146 Fc Silent Antibody (IR94)
[Cat#: CB-LX007-A]
Anti-CD194 Fc Silent Antibody (CB-LX007-A)
[Cat#: CB-LX008-A]
Anti-CD2 Fc Silent Antibody (hSC16)
[Cat#: CB-LX009-A]
Anti-CD20 Fc Silent Antibody (10F381)
[Cat#: CB-LX010-A]
Anti-CD20 Fc Silent Antibody (CB-LX010-A)
[Cat#: CB-LX011-A]
Anti-CD20 Fc Silent Antibody (CB-LX011-A)
[Cat#: CB-LX012-A]
Anti-CD20 Fc Silent Antibody (CB-LX012-A)
[Cat#: CB-LX013-A]
Anti-CD20 Fc Silent Antibody (CB-LX013-A)
[Cat#: CB-LX014-A]
Anti-CD20 Fc Silent Antibody (CB-LX014-A)
[Cat#: CB-LX015-A]
Anti-CD20 Fc Silent Antibody (1E11)
Biobetter Antibodies Betting on the Future Creative Biolabs Visit
All products and services are for Research Use Only. Do Not use in humans.